Extended Letrozole Sustains DFS Benefit at 15 Years in HR+ Breast Cancer - 世界杯直播
Extending letrozole (Femara) for 5 additional years showed a statistically significant improvement in disease-free survival (DFS) vs placebo in postmenopausal patients with hormone receptor (HR)-positive breast cancer who had completed prior adjuvant... [6224 chars]
2 Comments
Staff Editor
May 10, 2026 14:00Welcome to Global Match Focus. I'm your host, senior editor at the World Cup Official Website Chinese site, and today we break down the biggest stories from the tournament.
Community Manager Zhao Qiang
May 10, 2026 14:25Thrilled to join this panel — the upcoming clash is electric. Thanks for having me!